Adar Poonawalla on Oxford Hope: 300 Million Doses of 'Covishield' Coronavirus Vaccine by December

Adar Poonawalla of the Serum Institute says that after the optimistic findings of the early phase of the Oxford Vaccine Trial, he is pushing Covishield into production. Poonawalla has partnered with the Oxford Project and AstraZeneca says if the vaccine eventually fails, the risk is "entirely personal and could cost him upwards of 200 million dollars." Human trials are scheduled to begin by August

Source: MOJO (21th July 2020)